Preferred Label : EGFR Inhibitor WJ13404;
NCIt definition : An orally bioavailable, fourth-generation epidermal growth factor receptor (EGFR)
inhibitor, with potential antineoplastic activity. Upon oral administration, EGFR
inhibitor WJ13404 targets, binds to, and inhibits the activity of EGFR, including
wild-type EGFR and multiple EGFR resistance mutations, such as triple mutations Del19/T790M/C797S
and L858R/T790M/C797S. This prevents EGFR-mediated signaling, which induces cell death
and inhibits tumor growth in EGFR-overexpressing tumor cells. EGFR, a receptor tyrosine
kinase that is mutated in many tumor cell types, plays a key role in tumor cell proliferation
and tumor vascularization.;
Molecule name : WJ 13404; WJ-13404;
NCI Metathesaurus CUI : CL1905841;
Origin ID : C198691;
UMLS CUI : C5854364;
Semantic type(s)
concept_is_in_subset
has_target